95Fournier I, Gaucher D, Chich JF, Bach C, Shooshtarizadeh P, Picaud S, Bourcier T, Speeg-Schatz
C, Strub JM, Van Dorsselaer A, Corti A, Aunis D, Metz-Boutigue MH (2011) Processing of
chromogranins/secretogranin in patients with diabetic retinopathy. Regul Pept 167(1):118–
- doi:10.1016/j.regpep.2010.12.004
Gasparri A, Sidoli A, Sanchez LP, Longhi R, Siccardi AG, Marchisio PC, Corti A (1997)
Chromogranin A fragments modulate cell adhesion. Identification and characterization of a
pro-adhesive domain. J Biol Chem 272(33):20835–20843
Gayen JR, Saberi M, Schenk S, Biswas N, Vaingankar SM, Cheung WW, Najjar SM, O'Connor
DT, Bandyopadhyay G, Mahata SK (2009) A novel pathway of insulin sensitivity in chro-
mogranin A null mice: a crucial role for pancreastatin in glucose homeostasis. J Biol Chem
284(42):28498–28509. doi:10.1074/jbc.M109.020636
Giusti M, Sidoti M, Augeri C, Rabitti C, Minuto F (2004) Effect of short-term treatment with low
dosages of the proton-pump inhibitor omeprazole on serum chromogranin A levels in man. Eur
J Endocrinol 150(3):299–303
Glattard E, Angelone T, Strub JM, Corti A, Aunis D, Tota B, Metz-Boutigue MH, Goumon
Y (2006) Characterization of natural vasostatin-containing peptides in rat heart. FEBS
J 273(14):3311–3321
Gregorc V, Spreafico A, Floriani I, Colombo B, Ludovini V, Pistola L, Bellezza G, Vigano MG,
Villa E, Corti A (2007) Prognostic value of circulating chromogranin A and soluble tumor
necrosis factor receptors in advanced nonsmall cell lung cancer. Cancer 110(4):845–853
Helle KB, Corti A, Metz-Boutigue MH, Tota B (2007) The endocrine role for chromogranin A:
a prohormone for peptides with regulatory properties. Cell Mol Life Sci 64(22):2863–2886.
doi:10.1007/s00018-007-7254-0
Helpap B, Kollermann J (2001) Immunohistochemical analysis of the proliferative activity of neu-
roendocrine tumors from various organs. Are there indications for a neuroendocrine tumor-
carcinoma sequence? Virchows Archives 438(1):86–91
Hu G, Place AT, Minshall RD (2008) Regulation of endothelial permeability by Src kinase signal-
ing: vascular leakage versus transcellular transport of drugs and macromolecules. Chem Biol
Interact 171(2):177–189. doi:10.1016/j.cbi.2007.08.006
Imbrogno S, Angelone T, Corti A, Adamo C, Helle KB, Tota B (2004) Influence of vasostatins, the
chromogranin A-derived peptides, on the working heart of the eel (Anguilla anguilla): negative
inotropy and mechanism of action. Gen Comp Endocrinol 139(1):20–28
Iyoda A, Hiroshima K, Toyozaki T, Haga Y, Fujisawa T, Ohwada H (2001) Clinical characteriza-
tion of pulmonary large cell neuroendocrine carcinoma and large cell carcinoma with neuroen-
docrine morphology. Cancer 91(11):1992–2000
Jakob C, Sterz J, Zavrski I, Heider U, Kleeberg L, Fleissner C, Kaiser M, Sezer O (2006)
Angiogenesis in multiple myeloma. Eur J Cancer 42(11):1581–1590. doi:10.1016/j.
ejca.2006.02.017
Janson ET, Holmberg L, Stridsberg M, Eriksson B, Theodorsson E, Wilander E, Oberg K (1997)
Carcinoid tumors: analysis of prognostic factors and survival in 301 patients from a referral
center. Ann Oncol 8(7):685–690
Ji L, Pei ZQ, Ma DF, Zhang J, Su JS, Gao XD, Xue WZ, Chen XP, Wang WS (2012) Prognostic
value of circulating catestatin levels for in-hospital heart failure in patients with acute myocar-
dial infarction. Zhonghua Xin Xue Guan Bing Za Zhi 40(11):914–919
Kim T, Tao-Cheng JH, Eiden LE, Loh YP (2001) Chromogranin A, an “on/off”; switch controlling
dense-core secretory granule biogenesis. Cell 106(4):499–509
Komarova Y, Malik AB (2010) Regulation of endothelial permeability via paracellu-
lar and transcellular transport pathways. Annu Rev Physiol 72:463–493. doi:10.1146/
annurev-physiol-021909-135833
Koshimizu H, Kim T, Cawley NX, Loh YP (2010) Chromogranin A: a new proposal for trafficking,
processing and induction of granule biogenesis. Regul Pept 160(1–3):153–159. doi:10.1016/j.
regpep.2009.12.007
Chromogranin A in Endothelial Homeostasis and Angiogenesis